A number of stock research firms have changed their ratings and price targets for Reed Elsevier (LON: REL) during the last seven days:
- Reed Elsevier had its “add” rating reaffirmed by analysts at Numis Securities Ltd. They now have a $12.43 (820 GBX) price target on the stock.
- Reed Elsevier had its price target raised by analysts at UBS AG from $11.93 (787 GBX) to $12.24 (807 GBX). They now have a “buy” rating on the stock.
- Reed Elsevier had its “outperform” rating reaffirmed by analysts at BNP Paribas. They now have a $11.33 (748 GBX) price target on the stock.
- Reed Elsevier had its “overweight” rating reaffirmed by analysts at JPMorgan Chase.
- Reed Elsevier had its “buy” rating reaffirmed by analysts at Investec. They now have a $11.83 (780 GBX) price target on the stock.
- Reed Elsevier had its “add” rating reaffirmed by analysts at Numis Securities Ltd. They now have a $12.15 (801 GBX) price target on the stock.
Reed Elsevier opened at 709.00 on Friday. Reed Elsevier has a 1-year low of GBX 466.10 and a 1-year high of GBX 725.00. The stock’s 50-day moving average is currently GBX 599.8. The company’s market cap is £8.537 billion.
Reed Elsevier PLC is a provider of professional information solutions. As of December 31, 2011, the Company was organized in five business segments: Elsevier, providing scientific, technical and medical information solutions; LexisNexis Risk Solutions, providing risk information and analytics to business and government customers; LexisNexis Legal & Professional, providing legal, tax, regulatory and business information solutions to professionals, business and government customers; Reed Exhibitions, organising trade exhibitions and conferences, and Reed Business Information, providing information and marketing solutions to business professionals.
